The leading source for credible citizen reporting

Report Your News
Take the tour...

Bernstein Research: 4 good reasons to buy Teva

Source: Globes Online
Niš : Serbia | about 1 month ago  
Views: 1
Bernstein Research has outlined four good reasons to buy Teva's share. The report is headlined four under-appreciated catalysts and gives Teva an Outperform and gives Teva's share a target price of $58-60 in 2010. The share closed at $51.52 on Nasdaq on Friday, giving a market cap of $45.03 billion....
  • Print
  • Share:
  • Share
  • Digg
  • Reddit
  • Facebook
  • Stumbleupon

Related Allvoices Contributions

News Stories
 
  • News Source: Globes Online | about 1 month ago
    The Tel Aviv 25 Index fell 0.51% to 1,029.36 points; the Tel Aviv 100 Index fell 0.15% to 958.20 points; the Tel-Tech Index rose 3.09% to 229.69 points...U-turned and spent most of the session in negative territory. On the domestic scene, the Bank of...
  • News Source: Globes Online | about 1 month ago
    Bernstein Research has outlined four good reasons to buy Teva's share. The report is headlined four under-appreciated catalysts and gives Teva an Outperform and gives Teva's share a target price of $58-60 in 2010. The share closed at $51.52 on Nasdaq...
Report Your News Got a similar story?
Add it to the network!

Or add related content to this report

Cell phones Cell phones use report code: @4365026

Most Popular Reports

Related Allvoices Reports

Contributions

Help and Accounts


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2009. All rights reserved.